Araştırma Makalesi

Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

Cilt: 47 Sayı: 1 31 Mart 2022
PDF İndir
TR EN

Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

Öz

Purpose: The study aimed at determining the success rate of sequential multi-dose methotrexate treatment in tubal ectopic pregnancy (EP) patients and the prognostic factors affecting the treatment success. Materials and Methods: Clinical, laboratory, and demographic data of 63 patients -hospitalized with the diagnosis of EP in our tertiary center between 2017-2020 and administered sequential multiple-dose methotrexate treatment protocol- were analyzed in this retrospective study. Results: Based on research findings, medical treatment was successful in 45 of the patients. It was found that 16 out of 18-patient, 88.8% of the patients in the failed group with methotrexate treatment, were operated on due to tubal rupture during follow-up. The mean of sonographic free fluid in Douglas of the successful group with methotrexate treatment was found to be 2.40±0.70 mm (Mean±SE), while it was 10.38±3.05 mm (Mean±SE) in the failed group at the first consultation. The initial β-hCG value of the successful group with methotrexate treatment was measured 3668.55±440.55 IU/L (Mean±SE), while it was 4929.72±752.65 IU/L (Mean±SE) in the failed group. Conclusion: The success rate of the sequential multiple dose methotrexate protocol was 71.4%. Both the initial serum β-hCG level and the amount of sonographic free fluid in the pouch of Douglas were found high in the failed group with medical treatment at the first consultation.

Anahtar Kelimeler

Methotrexate, Ectopic Pregnancy, Tubal Rupture

Kaynakça

  1. Eriç HJ, Görkemli H, Özkaya EB, Işıkalan MM, Akıncı D, Kılıç F. Ektopik gebelik ve düşük tehdidi tanısında hemogram parametrelerinin değerlendirilmesi. Cukurova Med J. 2021;46:63-9.
  2. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J.. Ectopic Pregnancy. In Williams Obstetrics, 24th ed., New York, McGraw-Hill, 2014.
  3. Desroque D, Capmas P, Legendre G, Bouyer J, Fernandez H. Fertility after ectopic pregnancy. J Gynecol Obstet Biol Reprod (Paris). 2010;39:395-400.
  4. Spandana J, Tejaswini D, Bai GS. Clinical course of ectopic pregnancy: a tertiary centre experience. Int J Reprod Contracept Obstet Gynecol. 2017;6:2990-7.
  5. Baselice J, Yates M. Ectopic pregnancy. In The Johns Hopkins Manual of Gynecology and Obstetrics (Eds Hurt KJ, Guile MW, Bienstock JL, Fox HE, Wallach EE):340-9. New York, Lippincott Williams & Wilkins, 2012.
  6. van Mello NM, Mol F, Ankum WM, Mol BW, van der Veen F, Hajenius PJ. Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril. 2012;98:1066-73.
  7. Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ, Callaghan WM. Trends in ectopic pregnancy mortality in the United States: 1980-2007. Obstet Gynecol. 2011;117:837-43.
  8. Dhar H, Hamdi I, Rathi B. Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review. Oman Med J. 2011;26:94-8.
  9. Thacker J, Reardon R. Sonographic free fluid in patients with ectopic pregnancy. Ann Emerg Med. 2004;44:85.
  10. Sargin MA, Yassa M, Taymur BD, Çelik A, Aydin S, Orhan E et al. A clinical experience of ectopic pregnancies with initial free intraperitoneal fluid. J Clin Diagn Res. 2016;10:22-6.

Kaynak Göster

APA
Çetin, F., Bayramoğlu Tepe, N., Sucu, S., Bademkıran, M. H., & Kutlar, İ. (2022). Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies. Cukurova Medical Journal, 47(1), 397-404. https://doi.org/10.17826/cumj.1037172
AMA
1.Çetin F, Bayramoğlu Tepe N, Sucu S, Bademkıran MH, Kutlar İ. Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies. Cukurova Med J. 2022;47(1):397-404. doi:10.17826/cumj.1037172
Chicago
Çetin, Furkan, Neslihan Bayramoğlu Tepe, Seyhun Sucu, Muhammed Hanifi Bademkıran, ve İrfan Kutlar. 2022. “Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies”. Cukurova Medical Journal 47 (1): 397-404. https://doi.org/10.17826/cumj.1037172.
EndNote
Çetin F, Bayramoğlu Tepe N, Sucu S, Bademkıran MH, Kutlar İ (01 Mart 2022) Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies. Cukurova Medical Journal 47 1 397–404.
IEEE
[1]F. Çetin, N. Bayramoğlu Tepe, S. Sucu, M. H. Bademkıran, ve İ. Kutlar, “Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies”, Cukurova Med J, c. 47, sy 1, ss. 397–404, Mar. 2022, doi: 10.17826/cumj.1037172.
ISNAD
Çetin, Furkan - Bayramoğlu Tepe, Neslihan - Sucu, Seyhun - Bademkıran, Muhammed Hanifi - Kutlar, İrfan. “Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies”. Cukurova Medical Journal 47/1 (01 Mart 2022): 397-404. https://doi.org/10.17826/cumj.1037172.
JAMA
1.Çetin F, Bayramoğlu Tepe N, Sucu S, Bademkıran MH, Kutlar İ. Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies. Cukurova Med J. 2022;47:397–404.
MLA
Çetin, Furkan, vd. “Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies”. Cukurova Medical Journal, c. 47, sy 1, Mart 2022, ss. 397-04, doi:10.17826/cumj.1037172.
Vancouver
1.Furkan Çetin, Neslihan Bayramoğlu Tepe, Seyhun Sucu, Muhammed Hanifi Bademkıran, İrfan Kutlar. Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies. Cukurova Med J. 01 Mart 2022;47(1):397-404. doi:10.17826/cumj.1037172